Article preview from "The Gray Sheet"- July 25, 2011
The editors of three premier peer-reviewed medical journals say two widely circulated reports criticizing FDA's medical device review process are deeply flawed, biased and should play no part in discussions over FDA regulatory reforms.
Journal Editors Slam Industry-Funded Device Approval Studies
Article preview from "The Gray Sheet"- July 25, 2011
In written statements to House Energy and Commerce Committee Ranking Member Henry Waxman, D-Calif., the editors of the New England Journal of Medicine, the Journal of the American Medical Association and the Archives of Internal Medicine lambasted a November 2010 survey by professor and medical device entrepreneur Joshua Makower, and a February 2011 report by the California Healthcare Institute.
The statements were released at a July 20 hearing of the committee's oversight and investigations subcommittee. Waxman had asked the journal editors to review the two studies ahead of the hearing.
Makower and co-author Aabed Meer, a medical student, had surveyed 204 device companies, which largely agreed that FDA was less competent and less efficient than European regulatory authorities.
"It is not really a study at all," Gregory Curfman, executive editor of NEJM, wrote July 15. "This is an opinion piece that is dressed up to look like a research study."
Continued...
To read this article in its entirety, Purchase now as a PDF and receive it immediately via email. Or get it FREE when you subscribe to Medtech Insight Newsletter.
About Medtech Insight
Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices.
Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512






.jpg)

Comments